| NCT ID | NCT07216508 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Icahn School of Medicine at Mount Sinai |
| Condition | Liver Transplant |
| Study Type | OBSERVATIONAL |
| Enrollment | 40 participants |
| Start Date | 2025-10-13 |
| Primary Completion | 2026-10-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 40 participants in total. It began in 2025-10-13 with a primary completion date of 2026-10-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This investigator initiated study aims to describe continuous glucose monitoring (CGM) based glycemic metrics after discharge from liver transplant and assess relationship with glycemic metrics and liver transplant outcomes.
Eligibility Criteria
Inclusion Criteria: • inpatient liver transplant participants who have had an inpatient glucose greater than 180mg/dL Exclusion Criteria: * having a planned discharge to a rehabilitation or nursing facility, * a contraindication to sensor placement, * if discharge is anticipated to be \>30 days post-transplant, or * if recent transplant also included a kidney or pancreas transplant
Contact & Investigator
Grenye O'Malley, MD
PRINCIPAL INVESTIGATOR
Icahn School of Medicine at Mount Sinai
Frequently Asked Questions
Who can join the NCT07216508 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Liver Transplant. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07216508 currently recruiting?
Yes, NCT07216508 is actively recruiting participants. Contact the research team at grenye.o'malley@mssm.edu for enrollment information.
Where is the NCT07216508 trial being conducted?
This trial is being conducted at New York, United States.
Who is sponsoring the NCT07216508 clinical trial?
NCT07216508 is sponsored by Icahn School of Medicine at Mount Sinai. The principal investigator is Grenye O'Malley, MD at Icahn School of Medicine at Mount Sinai. The trial plans to enroll 40 participants.